Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.verified

CPRX

Price:

$31.36

Market Cap:

$3.84B

Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional appl...[Read more]

Industry

Biotechnology

IPO Date

2006-11-08

Stock Exchange

NASDAQ

Ticker

CPRX

The ROE as of June 2026 (TTM) for Catalyst Pharmaceuticals, Inc. (CPRX) is 23.65%

According to Catalyst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 23.65%. This represents a change of 300.20% compared to the average of 5.91% of the last 4 quarters.

Catalyst Pharmaceuticals, Inc. (CPRX) Historical ROE (quarterly & annually)

How has CPRX ROE performed in the past?

The mean historical ROE of Catalyst Pharmaceuticals, Inc. over the last ten years is 5.50%. The current 23.65% ROE has changed 329.62% with respect to the historical average. Over the past ten years (40 quarters), CPRX's ROE was at its highest in in the September 2020 quarter at 27.67%. The ROE was at its lowest in in the December 2018 quarter at -28.55%.

Quarterly (TTM)
Annual

Average

5.50%

Median

20.77%

Minimum

-66.96%

Maximum

44.21%

Catalyst Pharmaceuticals, Inc. (CPRX) ROE by Quarter and Year

Discovering the peaks and valleys of Catalyst Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 194.43%

Maximum Annual ROE = 44.21%

Minimum Annual Increase = -154.32%

Minimum Annual ROE = -66.96%

Quarterly (TTM)
Annual
YearROEChange
202522.46%-0.28%
202422.52%22.34%
202318.41%-33.43%
202227.65%44.87%
202119.09%-56.82%
202044.21%21.55%
201936.37%-154.32%
2018-66.96%194.43%
2017-22.74%-50.54%
2016-45.98%26.06%

Catalyst Pharmaceuticals, Inc. (CPRX) Average ROE

How has CPRX ROE performed in the past?

The current ROE of Catalyst Pharmaceuticals, Inc. (CPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.13%

5-year avg

22.03%

10-year avg

5.50%

Catalyst Pharmaceuticals, Inc. (CPRX) ROE vs. Peers

How is CPRX’s ROE compared to its peers?

Catalyst Pharmaceuticals, Inc.’s ROE is greater than Mineralys Therapeutics, Inc. (-27.92%), greater than Cidara Therapeutics, Inc. (-60.15%), less than Apellis Pharmaceuticals, Inc. (39.71%), greater than Beam Therapeutics Inc. (-5.89%), greater than Adaptive Biotechnologies Corporation (-24.26%), greater than Scholar Rock Holding Corporation (-163.52%), greater than IDEAYA Biosciences, Inc. (-13.96%), greater than Recursion Pharmaceuticals, Inc. (-54.32%), less than Kiniksa Pharmaceuticals, Ltd. (13.26%), greater than Agios Pharmaceuticals, Inc. (-34.11%),

Build a custom stock screener for Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Catalyst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Catalyst Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Catalyst Pharmaceuticals, Inc. (CPRX)?

What is the highest ROE for Catalyst Pharmaceuticals, Inc. (CPRX)?

What is the 3-year average ROE for Catalyst Pharmaceuticals, Inc. (CPRX)?

What is the 5-year average ROE for Catalyst Pharmaceuticals, Inc. (CPRX)?

How does the current ROE for Catalyst Pharmaceuticals, Inc. (CPRX) compare to its historical average?